BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Heart
,
Early pregnancy factor
,
Quercetin
,
rs2476601
,
FABP1
,
Angiogenesis
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
positive regulation of epidermal growth factor-activated receptor activity
(biogroup)
Summary
General Info
Body Atlas
Most Correlated Tissues
Pharyngeal mucosa
Oral mucosa
Tongue main corpus
Pituitary gland
Adrenal gland cortex
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Pyloric ulcer
Disease due to Enterovirus
Lamellar ichthyosis
Perforation of tympanic membrane
Spotted fevers
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
Carrageenan
temsirolimus
Probiotic mixture
OTS-167
CGP 60474
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
MAP3K4
IRF7
GALNT3
EXT2
RPL5
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
L1000 CMAP - Hepatocellular carcinoma HEPG2 cells treated with small molecule perturbagens
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)
L1000 CMAP - Prostate cancer LNCAP cells treated with small molecule perturbagens
Reprogramming of fibroblasts into embryonic Sertoli-like cells
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (2 of 4)
Explore Curated Studies Results
Literature
Most Relevant Literature
There were no matches for positive regulation of epidermal growth factor-activated receptor activity
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Trial to Evaluate the Therapeutic Benefit of Fulvestrant in Combination With ZACTIMA in Postmenopaus…
Pertuzumab in First Line Treatment of HER2-positive Metastatic Breast Cancer Patients
Lapatinib and RAD-001 for HER2 Positive Metastatic Breast Cancer
Efficacy and Safety Evaluation of the Intralesional Recombinant Human Epidermal Growth Factor (rhEGF…
Safety and Efficacy Study of Sapanisertib in Combination With Exemestane or Fulvestrant in Postmenop…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ